6. Endocrine System
| First line drugs | Second line drugs | Specialist drugs | Secondary care drugs |
| Recommended in both primary and secondary care | Alternatives (often in specific conditions) in both primary and secondary care; | Where a specialist input is needed (see introduction for definition) | Prescribing principally within secondary care only |
- Joint Formulary – Summary of available insulins
- 6.1.1 Insulins
- 6.1.2 Antidiabetic drugs
- 6.1.4 Treatment of hypoglycaemia
- 6.1.6 Diagnostic and monitoring devices for diabetes mellitus
- 6.2.1 Thyroid Hormones
- 6.2.2 Antithyroid drugs
- 6.3.1 Replacement therapy (mineralocorticoid)
- 6.3.2 Glucocorticoid therapy
- 6.4.1 Female Sex hormones
- 6.4.2 Male sex hormones and antagonists
- 6.5.1 Hypothalamic and pituitary hormones and anti–oestrogens
- 6.5.2 Posterior pituitary hormones and antagonists
- 6.6.1 Calcitonin and parathyroid hormone
- 6.6.2 Bisphosphonates
- 6.7.1 Bromocriptine and other dopamine–receptor stimulants
- 6.7.2 Drugs affecting gonadotrophins
- 6.7.3 Metyrapone
Appendices
- Algorithm for Primary and Secondary Prevention and Treatment of Osteoporosis in Men and Women
- Management of glucocorticoid induced osteoporosis in men and women
- Quick Guide Care Pathway for Blood Glucose Lowering Therapy in Type 2 Diabetes
Last updated by: Carol Webb on 02-12-2011 11:13
Please click on the links below for more information
-
BNF
-
NICE
-
Summary of product characteristics
